{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T00:57:26Z","timestamp":1716598646694},"reference-count":30,"publisher":"Japanese Society of Internal Medicine","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2015]]},"DOI":"10.2169\/internalmedicine.54.4493","type":"journal-article","created":{"date-parts":[[2015,8,31]],"date-time":"2015-08-31T22:09:58Z","timestamp":1441058998000},"page":"2121-2128","source":"Crossref","is-referenced-by-count":3,"title":["A Comparison of Quantitative T2 Mapping on Cardiovascular Magnetic Resonance Imaging with Metaiodobenzylguanidine Scintigraphy and Left Ventricular Functional Recovery in Dilated Cardiomyopathy: A Retrospective Pilot Study"],"prefix":"10.2169","volume":"54","author":[{"given":"Tatsuro","family":"Ito","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"K. Kono","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachiko","family":"Takamine","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Shigeru","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shumpei","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomofumi","family":"Takaya","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Nishii","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Shiotani","sequence":"additional","affiliation":[{"name":"Kobe University Graduate School of Health Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuro","family":"Sugimura","sequence":"additional","affiliation":[{"name":"Department of Radiology, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Hirata","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Felker GM, Thompson RE, Hare JM, et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med 342: 1077-1084, 2000.","DOI":"10.1056\/NEJM200004133421502"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Matsumura Y, Takata J, Kitaoka H, et al. Long-term prognosis of dilated cardiomyopathy revisited: an improvement in survival over the past 20 years. Circ J 70: 376-383, 2006.","DOI":"10.1253\/circj.70.376"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 10: 933-989, 2008.","DOI":"10.1016\/j.ejheart.2008.08.005"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Lapu-Bula R, Robert A, De Kock M, et al. Risk stratification in patients with dilated cardiomyopathy: contribution of Doppler-derived left ventricular filling. Am J Cardiol 82: 779-785, 1998.","DOI":"10.1016\/S0002-9149(98)00460-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Ungerer M, Böhm M, Elce JS, Erdmann E, Lohse MJ. Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart. Circulation 87: 454-463, 1993.","DOI":"10.1161\/01.CIR.87.2.454"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Caldwell JH, Link JM, Levy WC, Poole JE, Stratton JR. Evidence for pre- to postsynaptic mismatch of the cardiac sympathetic nervous system in ischemic congestive heart failure. J Nucl Med 49: 234-241, 2008.","DOI":"10.2967\/jnumed.107.044339"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Yamashina S, Yamazaki J. Neuronal imaging using SPECT. Eur J Nucl Med Mol Imaging 34: S62-S73, 2007.","DOI":"10.1007\/s00259-007-0441-2"},{"key":"8","unstructured":"8. Merlet P, Valette H, Dubois-Randé JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 33: 471-477, 1992."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Suwa M, Otake Y, Moriguchi A, et al. Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy. Am Heart J 133: 353-358, 1997.","DOI":"10.1016\/S0002-8703(97)70232-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Kakuchi H, Sasaki T, Ishida Y, Komamura K, Miyatake K. Clinical usefulness of 123I meta-iodobenzylguanidine imaging in predicting the effectiveness of beta blockers for patients with idiopathic dilated cardiomyopathy before and soon after treatment. Heart 81: 148-152, 1999.","DOI":"10.1136\/hrt.81.2.148"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Verhaert D, Thavendiranathan P, Giri S, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging 4: 269-278, 2011.","DOI":"10.1016\/j.jcmg.2010.09.023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Giri S, Chung YC, Merchant A, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson 11: 56, 2009.","DOI":"10.1186\/1532-429X-11-56"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Thavendiranathan P, Walls M, Giri S, et al. Improved detection of myocardial involvement in acute inflammatory cardiomyopathies using T2 mapping. Circ Cardiovasc Imaging 5: 102-110, 2012.","DOI":"10.1161\/CIRCIMAGING.111.967836"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Jeserich M, Föll D, Olschewski M, et al. Evidence of myocardial edema in patients with nonischemic dilated cardiomyopathy. Clin Cardiol 35: 371-376, 2012.","DOI":"10.1002\/clc.21979"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Nishii T, Kono AK, Shigeru M, et al. Cardiovascular magnetic resonance T2 mapping can detect myocardial edema in idiopathic dilated cardiomyopathy. Int J Cardiovasc Imaging 30: 65-72, 2014.","DOI":"10.1007\/s10554-014-0414-z"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation 93: 841-842, 1996.","DOI":"10.1161\/01.CIR.93.5.841"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105: 539-542, 2002.","DOI":"10.1161\/hc0402.102975"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18: 1440-1463, 2005.","DOI":"10.1016\/j.echo.2005.10.005"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Agostini D, Carrio I, Verberne HJ. How to use myocardial 123I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging 36: 555-559, 2009.","DOI":"10.1007\/s00259-008-0976-x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Schofer J, Spielmann R, Schuchert A, Weber K, Schlüter M. Iodine-123 meta-iodobenzylguanidine scintigraphy: a noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 12: 1252-1258, 1988.","DOI":"10.1016\/0735-1097(88)92608-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Ohshima S, Isobe S, Izawa H, et al. Cardiac sympathetic dysfunction correlates with abnormal myocardial contractile reserve in dilated cardiomyopathy patients. J Am Coll Cardiol 46: 2061-2068, 2005.","DOI":"10.1016\/j.jacc.2005.08.046"},{"key":"22","unstructured":"22. Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 40: 917-923, 1999."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Imamura Y, Fukuyama T, Mochizuki T, Miyagawa M, Watanabe K, Investigators EMHFS. Prognostic value of iodine-123-metaiodobenzylguanidine imaging and cardiac natriuretic peptide levels in patients with left ventricular dysfunction resulting from cardiomyopathy. Jpn Circ J 65: 155-160, 2001.","DOI":"10.1253\/jcj.65.155"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Turpeinen AK, Vanninen E, Magga J, et al. Cardiac sympathetic activity is associated with inflammation and neurohumoral activation in patients with idiopathic dilated cardiomyopathy. Clin Physiol Funct Imaging 29: 414-419, 2009.","DOI":"10.1111\/j.1475-097X.2009.00887.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. De Gennaro L, Brunetti ND, Cuculo A, Pellegrino PL, Di Biase M. Systemic inflammation in nonischemic dilated cardiomyopathy. Heart Vessels 23: 445-450, 2008.","DOI":"10.1007\/s00380-008-1075-4"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Assomull RG, Prasad SK, Lyne J, et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 48: 1977-1985, 2006.","DOI":"10.1016\/j.jacc.2006.07.049"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Wu KC, Weiss RG, Thiemann DR, et al. Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol 51: 2414-2421, 2008.","DOI":"10.1016\/j.jacc.2008.03.018"},{"key":"28","unstructured":"28. Lehrke S, Lossnitzer D, Schöb M, et al. Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure: prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97: 727-732, 2011."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Maestrini V, Treibel TA, White SK, Fontana M, Moon JC. T1 mapping for characterization of intracellular and extracellular myocardial diseases in heart failure. Curr Cardiovasc Imaging Rep 7: 9287, 2014.","DOI":"10.1007\/s12410-014-9287-8"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Smith GL, Vaccarino V, Kosiborod M, et al. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9: 13-25, 2003.","DOI":"10.1054\/jcaf.2003.3"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4493\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T01:26:50Z","timestamp":1567128410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/54\/17\/54_54.4493\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015]]},"references-count":30,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.54.4493","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015]]}}}